EUR 118.6
(-0.08%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 439.1 Million EUR | -21.56% |
2022 | 559.8 Million EUR | -27.11% |
2021 | 768 Million EUR | 39.33% |
2020 | 551.2 Million EUR | 66.58% |
2019 | 330.9 Million EUR | -8.97% |
2018 | 363.5 Million EUR | 8.6% |
2017 | 334.7 Million EUR | 12.39% |
2016 | 297.8 Million EUR | 14.54% |
2015 | 260 Million EUR | 14.64% |
2014 | 226.8 Million EUR | -13.57% |
2013 | 262.39 Million EUR | 11.66% |
2012 | 235 Million EUR | -4.24% |
2011 | 245.4 Million EUR | 0.57% |
2010 | 244 Million EUR | 19.78% |
2009 | 203.7 Million EUR | 9.46% |
2008 | 186.1 Million EUR | 24.15% |
2007 | 149.9 Million EUR | -1.7% |
2006 | 152.5 Million EUR | 9.79% |
2005 | 138.9 Million EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 268.1 Million EUR | 0.0% |
2023 Q2 | 187 Million EUR | 0.0% |
2023 FY | 439.1 Million EUR | -21.56% |
2023 Q4 | 219.1 Million EUR | 0.0% |
2022 Q4 | 265.3 Million EUR | 0.0% |
2022 Q2 | 265.5 Million EUR | 0.0% |
2022 FY | 559.8 Million EUR | -27.11% |
2021 FY | 768 Million EUR | 39.33% |
2021 Q4 | 394 Million EUR | 0.0% |
2021 Q2 | 345.6 Million EUR | 0.0% |
2020 Q2 | 224.7 Million EUR | 0.0% |
2020 Q4 | 326.5 Million EUR | 0.0% |
2020 FY | 551.2 Million EUR | 66.58% |
2019 Q2 | 172.6 Million EUR | 0.0% |
2019 FY | 330.9 Million EUR | -8.97% |
2019 Q4 | 158.3 Million EUR | 0.0% |
2018 Q2 | 185.6 Million EUR | 0.0% |
2018 FY | 363.5 Million EUR | 8.6% |
2018 Q4 | 177.9 Million EUR | 0.0% |
2017 Q2 | 172.4 Million EUR | 0.0% |
2017 FY | 334.7 Million EUR | 12.39% |
2017 Q4 | 162.3 Million EUR | 0.0% |
2016 Q4 | 148.4 Million EUR | 0.0% |
2016 Q2 | 149.4 Million EUR | 0.0% |
2016 FY | 297.8 Million EUR | 14.54% |
2015 FY | 260 Million EUR | 14.64% |
2015 Q4 | 137.9 Million EUR | 0.0% |
2015 Q2 | 122.1 Million EUR | 0.0% |
2014 Q2 | 90.8 Million EUR | 0.0% |
2014 FY | 226.8 Million EUR | -13.57% |
2014 Q4 | 136 Million EUR | 0.0% |
2013 Q4 | 137.4 Million EUR | 0.0% |
2013 Q2 | 125 Million EUR | 0.0% |
2013 FY | 262.39 Million EUR | 11.66% |
2012 Q1 | 65.1 Million EUR | 0.0% |
2012 Q3 | 65.1 Million EUR | 0.0% |
2012 Q2 | - EUR | -100.0% |
2012 Q4 | - EUR | -100.0% |
2012 FY | 235 Million EUR | -4.24% |
2011 Q1 | 64.4 Million EUR | 0.0% |
2011 Q4 | - EUR | -100.0% |
2011 FY | 245.4 Million EUR | 0.57% |
2011 Q3 | 64.4 Million EUR | 0.0% |
2011 Q2 | - EUR | -100.0% |
2010 Q1 | 61 Million EUR | 0.0% |
2010 Q3 | 61 Million EUR | 0.0% |
2010 FY | 244 Million EUR | 19.78% |
2010 Q4 | - EUR | -100.0% |
2010 Q2 | - EUR | -100.0% |
2009 FY | 203.7 Million EUR | 9.46% |
2009 Q3 | 50.92 Million EUR | 0.0% |
2009 Q4 | - EUR | -100.0% |
2009 Q1 | 50.92 Million EUR | 8.99% |
2009 Q2 | 50.92 Million EUR | 0.0% |
2008 Q1 | 46.72 Million EUR | 11.92% |
2008 Q4 | 46.72 Million EUR | 0.0% |
2008 Q3 | 46.72 Million EUR | 0.0% |
2008 Q2 | 46.72 Million EUR | 0.0% |
2008 FY | 186.1 Million EUR | 24.15% |
2007 Q1 | 41.75 Million EUR | 11.78% |
2007 Q4 | 41.75 Million EUR | 0.0% |
2007 Q3 | 41.75 Million EUR | 0.0% |
2007 Q2 | 41.75 Million EUR | 0.0% |
2007 FY | 149.9 Million EUR | -1.7% |
2006 Q4 | 37.35 Million EUR | 0.0% |
2006 FY | 152.5 Million EUR | 9.79% |
2006 Q1 | 37.35 Million EUR | 7.64% |
2006 Q2 | 37.35 Million EUR | 0.0% |
2006 Q3 | 37.35 Million EUR | 0.0% |
2005 FY | 138.9 Million EUR | 0.0% |
2005 Q3 | 34.7 Million EUR | 0.0% |
2005 Q2 | 34.7 Million EUR | 0.0% |
2005 Q4 | 34.7 Million EUR | 0.0% |
2005 Q1 | 34.7 Million EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Biosynex SA | -37.4 Million EUR | 1273.939% |
Predilife S.A. | -3.83 Million EUR | 11535.194% |
Eurofins Scientific SE | 717 Million EUR | 38.759% |
Lumibird SA | 12.17 Million EUR | -3507.46% |